• 1. An AuNPs-functionalized AlGaN/GaN high electron mobility transistor sensor for ultrasensitive detection of TNT?
  Ying Li,Weirong Yao,Yunfei Xie,Renjun Pei RSC Adv., 2015,5, 98724-98729
• 2. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 3. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 4. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 5. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948

Recent Advances in the Study of Methyl 5-Nitro-1H-Indazole-3-Carboxylate (CAS: 78155-75-6): A Comprehensive Research Brief

Methyl 5-nitro-1H-indazole-3-carboxylate (CAS: 78155-75-6) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile applications in drug discovery and development. Recent studies have explored its potential as a key intermediate in the synthesis of bioactive molecules, particularly those targeting cancer, inflammation, and infectious diseases. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its synthetic utility, biological activities, and mechanistic insights.

One of the most notable advancements in the study of methyl 5-nitro-1H-indazole-3-carboxylate is its role as a precursor in the synthesis of indazole-based kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent inhibitory activity against cyclin-dependent kinases (CDKs), which are critical regulators of cell cycle progression. The study employed a combination of molecular docking and kinetic assays to elucidate the binding modes of these derivatives, revealing a strong correlation between the nitro and carboxylate functionalities and their inhibitory potency.

In addition to its applications in oncology, methyl 5-nitro-1H-indazole-3-carboxylate has also been investigated for its anti-inflammatory properties. A recent preprint on bioRxiv reported that this compound can modulate the activity of NF-κB, a transcription factor involved in the regulation of inflammatory responses. The researchers utilized a series of in vitro and in vivo experiments to demonstrate that methyl 5-nitro-1H-indazole-3-carboxylate derivatives significantly reduce the production of pro-inflammatory cytokines, such as TNF-α and IL-6, in murine models of acute inflammation.

Another area of interest is the antimicrobial potential of methyl 5-nitro-1H-indazole-3-carboxylate. A 2022 study in the European Journal of Medicinal Chemistry highlighted its efficacy against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). The study attributed this activity to the compound's ability to disrupt bacterial cell wall synthesis, as evidenced by electron microscopy and proteomic analyses. These findings suggest that methyl 5-nitro-1H-indazole-3-carboxylate could serve as a promising scaffold for the development of novel antibiotics.

Despite these promising results, challenges remain in optimizing the pharmacokinetic and pharmacodynamic properties of methyl 5-nitro-1H-indazole-3-carboxylate derivatives. Recent computational studies have focused on improving their bioavailability and reducing off-target effects. For instance, a 2023 paper in ACS Omega employed quantum mechanical calculations and molecular dynamics simulations to predict the metabolic stability of these compounds, providing valuable insights for future structural modifications.

In conclusion, methyl 5-nitro-1H-indazole-3-carboxylate (CAS: 78155-75-6) continues to be a molecule of great interest in chemical biology and medicinal chemistry. Its diverse biological activities and synthetic versatility make it a valuable tool for drug discovery. Future research should focus on addressing the current limitations and exploring its potential in other therapeutic areas, such as neurodegenerative diseases and metabolic disorders.

• 857801-97-9(6-Nitro-1H-indazole-3-carboxylic acid)
• 1000342-31-3(6-Chloro-4-nitro-3-(1H)indazole Methyl Carboxylate)
• 1167056-71-4(Methyl 6-nitro-1H-indazole-3-carboxylate)
• 78155-76-7(5-Nitro-1H-indazole-3-carboxylic Acid)
• 660411-95-0(Methyl 5-amino-1H-indazole-3-carboxylate)
• 78155-85-8(ETHYL 5-NITRO-1H-INDAZOLE-3-CARBOXYLATE)
• 851652-52-3(methyl 6-amino-1H-indazole-3-carboxylate)
• 1245645-05-9(6-Chloro-5-nitro-1H-indazole-3-carboxylic acid)
• 1058740-88-7(methyl 1-methyl-6-nitro-indazole-3-carboxylate)
• 660823-32-5(7-Nitro-1H-indazole-3-carboxylic acid)